The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment
Open accessAbstract
BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) is curable with chemotherapy in approximately 80 percent of patients. However, the cause of treatment failure in the remaining 20 percent of patients is largely unknown. METHODS: We tested leukemia cells from 173 children for sensitivity in vitro to prednisolone, vincristine, asparaginase, and daunorubicin. The cells were then subjected to an assessment of gene expression with the use of 14,500 probe sets to identify differentially expressed genes in drug-sensitive and drug-resistant ALL. Gene-expression patterns that differed according to sensitivity or resistance to the four drugs were compared with treatment outcome in the original 173 patients and an independent cohort of 98 children treated with the same drugs at another institution. RESULTS: We identified sets of differentially expressed genes in B-lineage ALL that were sensitive or resistant to prednisolone (33 genes), vincristine (40 genes), asparaginase (35 genes), or daunorubicin (20 genes). A combined gene-expression score of resistance to the four drugs, as compared with sensitivity to the four, was significantly and independently related to treatment outcome in a multivariate analysis (hazard ratio for relapse, 3.0; P=0.027). Results were confirmed in an independent population of patients treated with the same medications (hazard ratio for relapse, 11.85; P=0.019). Of the 124 genes identified, 121 have not previously been associated with resistance to the four drugs we tested. CONCLUSIONS: Differential expression of a relatively small number of genes is associated with drug resistance and treatment outcome in childhood ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Self-citationRho GTPases and signaling networks
Van Aelst, L., & D’Souza-Schorey, C. (1997) · Genes & Development · doi:10.1101/gad.11.18.2295 · Cited by 2,358
Yeoh, E.-J., Ross, M. E., Shurtleff, S. A., Williams, W. K., Patel, D., Mahfouz, R., Behm, F. G., Raimondi, S. C., Relling, M. V., Patel, A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00032-6 · Cited by 1,917
Self-citationMLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
Self-citationAn Information-Intensive Approach to the Molecular Pharmacology of Cancer
Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fornace, A. J., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., et al. (1997) · Science · doi:10.1126/science.275.5298.343 · Cited by 1,183
Pui, C.-H., & Evans, W. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390907 · Cited by 832
Self-citationMoving towards individualized medicine with pharmacogenomics
Evans, W. E., & Relling, M. V. (2004) · Nature · doi:10.1038/nature02626 · Cited by 768
Self-citationChemosensitivity prediction by transcriptional profiling
Staunton, J. E., Slonim, D. K., Coller, H. A., Tamayo, P., Angelo, M. J., Park, J., Scherf, U., Lee, J. K., Reinhold, W. O., Weinstein, J. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191368598 · Cited by 684
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling
Ross, M. E., Zhou, X., Song, G., Shurtleff, S. A., Girtman, K., Williams, W. K., Liu, H.-C., Mahfouz, R., Raimondi, S. C., Lenny, N., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0338 · Cited by 590
Bagging to improve the accuracy of a clustering procedure
Dudoit, S., & Fridlyand, J. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg038 · Cited by 530
McLeod, H., Krynetski, E., Relling, M., & Evans, W. (2000) · Leukemia · doi:10.1038/sj.leu.2401723 · Cited by 437
Self-citationKaspers, G. J. L., Veerman, A. J. P., Pieters, R., Van Zantwijk, C. H., Smets, L. A., Van Wering, E. R., & Van Der Does-Van Den Berg, A. (1997) · Blood · doi:10.1182/blood.v90.7.2723 · Cited by 271
Self-citationChildhood acute lymphoblastic leukaemia – current status and future perspectives
Pui, C.-H., Campana, D., & Evans, W. E. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00516-2 · Cited by 268
Self-citationCheok, M. H., Yang, W., Pui, C.-H., Downing, J. R., Cheng, C., Naeve, C. W., Relling, M. V., & Evans, W. E. (2003) · Nature Genetics · doi:10.1038/ng1151 · Cited by 249
Self-citationPieters, R., Huismans, D. R., Loonen, A. H., Veerman, A. J. P., Hahlen, K., van der Does-van den Berg, A., & Wering, E. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)91029-t · Cited by 216
Self-citationStam, R. W. (2002) · Blood · doi:10.1182/blood-2002-05-1600 · Cited by 203
Results of Therapy for Acute Lymphoblastic Leukemia in Black and White Children
Pui, C.-H. (2003) · JAMA · doi:10.1001/jama.290.15.2001 · Cited by 199
Self-citationDen Boer, M. L., Harms, D. O., Pieters, R., Kazemier, K. M., Göbel, U., Körholz, D., Graubner, U., Haas, R. J., Jorch, N., Spaar, H. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.031 · Cited by 184
Self-citationProkop, A., Wieder, T., Sturm, I., Eβmann, F., Seeger, K., Wuchter, C., Ludwig, W.-D., Henze, G., Dörken, B., & Daniel, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401866 · Cited by 183
Zembutsu, H., Ohnishi, Y., Tsunoda, T., Furukawa, Y., Katagiri, T., Ueyama, Y., Tamaoki, N., Nomura, T., Kitahara, O., Yanagawa, R., et al. (2002) · PubMed · Cited by 182
Krajinović, M., Labuda, D., Mathonnet, G., Labuda, M., Moghrabi, A., Champagne, J., & Sinnett, D. (2002) · PubMed · Cited by 162
Woerden, N. L. R.-V., Pieters, R., Loonen, A. H., Hubeek, I., van Drunen, E., Beverloo, H. B., Slater, R. M., Harbott, J., Seyfarth, J., van Wering, E. R., et al. (2000) · PubMed · Cited by 151
Self-citationGu, L., Findley, H. W., & Zhou, M. (2002) · Blood · doi:10.1182/blood.v99.9.3367 · Cited by 130
van den Heuvel‐Eibrink, M. M., Sonneveld, P., & Pieters, R. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38094 · Cited by 124
Self-citationHarms, D., Göbel, U., Spaar, H., Graubner, U. B., Jorch, N., Gutjahr, P., Janka-Schaub, G. E., & for the COALL Study Group (2003) · Blood · doi:10.1182/blood-2002-08-2372 · Cited by 85
Self-citationKearns, P. R., Pieters, R., Rottier, M. M. A., Pearson, A. D. J., & Hall, A. G. (2001) · Blood · doi:10.1182/blood.v97.2.393 · Cited by 45
Self-citationWoerden, N. L. R.-V., Pieters, R., Slater, R. M., Loonen, A. H., Beverloo, H. B., van Drunen, E., Heyman, M. M., Moreno, T. C., Rots, M. G., Wering, E. R., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02586.x · Cited by 33
Self-citationMartell, R. L., Slapak, C., & Levy, S. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.27 · Cited by 22
Molecular Pharmacodynamics in Childhood Leukemia
Pieters, R., & den Boer, M. L. (2003) · International Journal of Hematology · doi:10.1007/bf02983812 · Cited by 8
Self-citation
Cited by
Treatment of Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 1,976
Self-citationPui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Self-citationChildhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Pui, C.-H., Yang, J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., Vora, A., Baruchel, A., Silverman, L. B., Schmiegelow, K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1636 · Cited by 1,007
Self-citationDen Boer, M. L., van Slegtenhorst, M., De Menezes, R. X., Cheok, M. H., Buijs-Gladdines, J. G., Peters, S. T., Van Zutven, L. J., Beverloo, H. B., Van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 930
Self-citationSirota, M., Dudley, J. T., Kim, J., Chiang, A. P., Morgan, A. A., Sweet-Cordero, A., Sage, J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001318 · Cited by 799
Metadata
- Authors
- Holleman, A., Cheok, M. H., den Boer, M. L., Yang, W., Veerman, A. J. P., Kazemier, K. M., Pei, D., Cheng, C., Pui, C.-H., Relling, M. V., Janka-Schaub, G. E., Pieters, R., & Evans, W. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-05
- Volume
- 351
- Issue
- 6
- Pages
- 533-542
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2165207521
- Cited by
- 633
- References
- 31
- FWCI
- 52.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.